Even if SCOTUS rules IPRs are unconstitutional not much will change; though it could be bad news for branded pharma. https://t.co/bNA2R1f0AW
It is anti-patent to seek to curtail the rights of all patent owners on the back of little to no credible data:… https://t.co/YNZxT2BCo1
"If you're explaining, you're losing," said Reagan. The STRONGER Patents Act has the anti-patent lobby explaining. https://t.co/n4K6JKbxFK
Even if IPRs are deemed unconstitutional, not much will change - except for pharma sector, which will hate it
Since the US Supreme Court granted cert in Oil States Energy Services, a case which challenges the constitutionality of the IPR process, the patent community has been debating whether this might mark the end of post-issuance reviews. If that were to happen, what might it mean for the patent market? According to this guest blog from Zachary Silbersher of Kroub Silbersher & Kolmykov the...
A lot of the activity going on in the China market is so-called soft licensing. Rather than showing up with claim charts in hand, Western technology executives are exploring ways that they can work together with Chinese partners. It’s certainly safer and may well be a smarter approach. One of the more active participants in this trend has been General Electric. At IPBC Global in Ottawa...
Pro-patent legislation introduced yesterday is unlikely to make it out of US Congress, but it's still smart politics
The STRONGER Patent Act - a bipartisan bill introduced into the US Senate yesterday by Democrats Chris Coons (Delaware), Dick Durbin (Illinois) and Mazie Hirono (Hawaii), and Arkansas Republican Tom Cotton – is almost certain not to make it onto the statute books; but it is important nonetheless. Proposing to “to strengthen the US patent system through implementing measures to...
IAM Patent 1000
The definitive guide to leading patent lawyers, attorneys and firms in over 40 jurisdictions, with a special section on expert witnesses in the United States.Visit site